decemb
outbreak
unexplain
pneumonia
wuhan
citi
hubei
provinc
china
jan
confirm
new
type
coronaviru
name
formerli
name
emerg
world
health
organ
name
wuhan
pneumonia
coronaviru
feb
patient
show
typic
respiratori
symptom
cough
fever
lung
damag
symptom
fatigu
myalgia
diarrhea
februari
total
case
infect
pneumonia
report
china
countri
case
found
china
due
rapid
spread
humantohuman
transmiss
case
current
continu
rise
extract
patient
pneumonia
wuhan
envelop
singl
strand
rnatyp
betacoronaviru
genom
sequenc
share
sequenc
ident
sever
acut
respiratori
syndromerel
coronavirus
sarscov
addit
spike
protein
sarscov
enter
human
alveolar
epitheli
cell
bind
angiotensin
convert
enzym
receptor
diagnos
either
chest
ct
radiographi
laboratori
test
unfortun
specif
antivir
drug
vaccin
current
avail
treatment
accord
current
clinic
guidelin
china
experi
treatment
sar
middl
east
respiratori
syndrom
mer
patient
convent
medicin
tradit
chines
medicin
tcm
use
treatment
patient
infect
china
review
mainli
focus
discuss
tcm
usag
treatment
patient
context
current
convent
manag
due
homolog
epidemiolog
genom
pathogenesi
sarscov
wide
usag
tcm
treatment
patient
infect
sarscov
clinic
evid
show
efficaci
safeti
tcm
treatment
patient
emerg
coronavir
summar
analyz
includ
laboratori
studi
provid
insight
molecular
basi
therapeut
benefit
due
absenc
specif
antivir
therapeut
vaccin
main
treatment
strategi
support
care
supplement
combin
broadspectrum
antibiot
antivir
corticosteroid
convalesc
plasma
tabl
hiv
proteas
inhibitor
ritonavir
lopinavir
use
typic
combin
appropri
antibiot
treatment
infect
patient
nucleosid
analog
ribavirin
may
potenti
benefici
treatment
sinc
ribavirin
approv
treat
respiratori
syncyti
viru
rsv
infect
use
extens
sar
mer
outbreak
howev
ribavirin
sever
side
effect
anemia
whether
suffici
antivir
activ
unclear
nucleosid
analog
favipiravir
effect
inhibit
activ
rna
polymeras
rna
virus
influenza
recent
vitro
studi
found
activ
vivo
effect
remain
elus
remdesivir
may
promis
antivir
drug
treat
vitro
vivo
antivir
activ
wide
array
rna
virus
includ
sar
mer
could
decreas
viral
load
patholog
lung
anim
model
studi
show
remdesivir
markedli
inhibit
infect
vero
cell
symptom
first
us
patient
infect
resolv
swiftli
intraven
administr
remdesivir
current
clinic
trial
evalu
safeti
efficaci
intraven
remdesivir
patient
infect
oral
oseltamivir
use
treatment
case
efficaci
current
remain
uncertain
hosttarget
small
molecul
approv
human
diseas
may
modul
virushost
interact
chloroquin
potenti
broadspectrum
antivir
drug
shown
recent
studi
activ
clinic
efficaci
studi
openlabel
trial
million
u
atom
inhal
recommend
antivir
therapi
treat
trial
test
combin
approv
antihcv
inhibitor
initi
howev
whether
could
act
synergist
unclear
corticosteroid
frequent
use
suppress
elev
cytokin
level
patient
sarscov
merscov
howev
evid
show
mortal
sar
mer
patient
reduc
treatment
corticosteroid
clearanc
viral
delay
treatment
consequ
corticosteroid
suggest
system
use
infect
patient
previous
shown
either
sever
influenza
sarscov
infect
convalesc
plasma
treatment
could
significantli
decreas
viral
load
reduc
mortal
convalesc
plasma
use
sever
infect
china
although
promis
efficaci
safeti
need
care
evalu
consist
previou
analysi
also
conclud
date
specif
medicin
recommend
prevent
treat
tcm
use
control
infecti
diseas
thousand
year
clear
room
intervent
tcm
complementari
therapi
patient
report
patient
sarscov
infect
benefit
tcm
treatment
includ
amelior
side
effect
convent
therapeut
base
factor
gener
expect
tcm
would
valuabl
weapon
armori
applic
tcm
treatment
larg
inspir
treatment
sar
caus
outbreak
sar
coronaviru
sarscov
late
guangdong
provinc
china
spread
rapidli
cumul
number
worldwid
rang
case
report
case
seri
control
observ
studi
random
clinic
trial
clinic
studi
aim
examin
effect
tcm
sar
carri
report
quit
compel
evid
support
notion
tcm
benefici
effect
treatment
prevent
sar
exampl
rate
fatal
hong
kong
singapor
approxim
rate
beij
initi
may
decreas
gradual
may
dramat
reduc
fatal
late
may
beij
believ
associ
use
tcm
supplement
convent
therapi
lau
colleagu
report
sar
outbreak
volunt
includ
hospit
worker
laboratori
technician
work
highrisk
viru
laboratori
use
tcm
herbal
extract
name
sang
ju
yin
plu
yu
ping
feng
san
compar
infect
control
group
none
tcm
user
infect
furthermor
evid
sang
ju
yin
plu
yu
ping
feng
san
could
modul
cell
manner
enhanc
host
defens
capac
control
clinic
studi
supplementari
treatment
tcm
result
mark
improv
symptom
shorten
diseas
cours
clinic
benefici
effect
tcm
appear
support
laboratori
studi
exampl
highprofil
research
publish
lancet
report
glycyrrhizin
major
activ
constitu
liquoric
root
frequent
use
chines
herb
potent
inhibit
replic
clinic
isol
sar
viru
anoth
independ
studi
confirm
antiviru
activ
glycyrrhizin
plaqu
reduct
assay
studi
found
anoth
chines
herbal
compound
baicalin
also
antisar
activ
furthermor
wang
et
al
found
compound
deriv
tcm
may
becom
lead
compound
sar
therapi
inhibit
cathepsin
l
target
treatment
sar
myriad
literatur
tcm
treatment
sar
publish
sar
epidem
china
critic
analysi
public
would
use
confirm
benefici
effect
tcm
liu
et
al
systemat
review
eight
random
control
trial
conclud
combin
convent
medicin
tcm
show
benefici
effect
decreas
mortal
relief
symptom
well
control
fungal
infect
patient
sar
howev
evid
suffici
enough
due
poor
qualiti
methodolog
use
trial
leung
analyz
peerreview
paper
reason
qualiti
public
conclud
tcm
use
togeth
convent
treatment
posit
effect
includ
better
control
fever
quicker
clearanc
chest
infect
symptom
howev
benefici
effect
tcm
conclus
highqual
clinic
studi
requir
anoth
thorough
literatur
analysi
liu
colleagu
conclud
benefit
adjuv
treatment
tcm
term
mortal
due
lack
high
qualiti
tcm
trial
bias
influenc
valid
result
wu
colleagu
suggest
rerun
clinic
trial
tcm
treatment
acut
respiratori
tract
infect
arti
natur
product
use
tcm
remain
wealthi
sourc
identif
novel
therapeut
agent
treatment
human
diseas
past
decad
scientist
made
consider
effort
identifi
multipl
compon
herbal
formula
tcm
antisarscov
activ
tabl
identif
chemic
entiti
contain
tcm
herb
respons
antisar
cov
effect
also
pursu
tabl
due
homolog
sarscov
previou
studi
may
shed
light
natur
occur
compound
capac
inhibit
chymotrypsinlik
proteas
vital
replic
viru
thu
repres
promis
drug
target
develop
therapeut
agent
sarscov
well
human
coronavirus
includ
report
follow
tcm
herbal
extract
capac
inhibit
enzymat
activ
sar
chines
rhubarb
extract
water
extract
houttuynia
cordata
flavonoid
extract
litchi
seed
betasitosterol
extract
root
extract
isati
indigotica
follow
herbderiv
natur
occur
compound
includ
sinigrin
indigo
aloeemodin
hesperetin
quercetin
epigallocatechin
gallat
gallocatechin
gallat
herbacetin
rhoifolin
pectolinarin
abl
inhibit
sar
activ
moreov
flavonoid
name
herbacetin
isobavaschalcon
quercetin
helichrysetin
potenti
block
enzymat
activ
proteas
helicas
protein
also
consid
potenti
target
develop
antihcov
human
coronaviru
agent
yu
et
al
report
scutellarein
myricetin
potent
inhibit
sarscov
helicas
protein
vitro
affect
atpas
activ
rna
depend
rna
polymeras
rdrp
key
enzym
respons
posit
negativestrand
rna
synthesi
also
repres
anoth
potenti
druggabl
target
shown
extract
kang
du
bu
fei
tang
sinomenium
acutum
coriolu
versicolor
ganoderma
lucidum
inhibit
sarscov
rdrp
dose
depend
manner
wu
et
al
perform
larg
scale
screen
exist
drug
natur
product
synthet
compound
compound
identifi
effect
antisarscov
agent
cellbas
assay
sar
viru
vero
cell
found
isol
panax
ginseng
aescin
isol
hors
chestnut
tree
reserpin
contain
genu
rauwolfia
extract
eucalyptu
lonicera
japonica
inhibit
sarscov
replic
nontox
concentr
sarscov
use
host
receptor
cellular
entranc
therefor
tcm
capac
target
hold
promis
prevent
infect
emodin
genu
rheum
polygonum
baicalin
scutellaria
baicalensi
nicotianamin
foodstuff
especi
soybean
inhibitor
scutellarin
tgg
galla
chinensi
luteolin
veronicalina
riifolia
markedli
inhibit
interact
sarscov
sprotein
howev
antisarscov
activ
compound
remain
evalu
addit
inhibit
ion
channel
emodin
kaempferol
deriv
juglanin
could
potenti
prevent
viral
releas
infect
cell
saikosaponin
glycyrrhizin
quercetin
extract
toona
sinensi
roem
purportedli
potent
antisarscov
effect
inhibit
viral
cellular
entri
adsorpt
penetr
overwhelm
inflammatori
respons
attribut
death
patient
infect
sarscov
merscov
thu
antiinflammatori
agent
presum
could
reduc
sever
mortal
rate
shuang
huang
lian
tcm
herbal
product
prepar
lonicera
japonica
flo
scutellaria
radix
fructu
forsythia
purportedli
activ
inhibit
interestingli
shown
herbal
prepar
potent
inhibit
staphylococc
toxic
shock
syndrom
toxin
induc
product
cytokin
chemokin
peripher
blood
mononuclear
cell
pbmc
line
result
herbal
product
shown
markedli
reduc
transcript
translat
level
inflammatori
cytokin
lipopolysaccharidestimul
murin
alveolar
macrophag
indirubin
activ
ingredi
tcm
prepar
dang
gui
long
hui
pill
strong
antivir
immunomodulatori
effect
shown
studi
base
observ
influenza
virusinfect
human
macrophag
typei
alveolar
epitheli
cell
lian
hua
qing
wen
capsul
report
vitro
activ
inhibit
propag
variou
influenza
virus
tcm
herbal
product
block
earli
stage
influenza
viru
infect
also
inhibit
virusinduc
gene
express
tnfa
addit
studi
dong
et
al
report
level
sputum
blood
markedli
decreas
lian
hua
qing
wen
capsul
treatment
patient
acut
exacerb
chronic
obstruct
pulmonari
diseas
selfcontrol
studi
poon
et
al
show
administr
tcm
herbal
formula
sang
ju
yin
yu
ping
feng
san
may
benefici
immunomodulatori
effect
prevent
viral
infect
includ
sarscov
moreov
number
anticoronavir
agent
identifi
tcm
herb
although
mechan
action
yet
elucid
exampl
extract
lycori
radiata
artemisia
annua
pyrrosia
lingua
lindera
aggreg
possess
activ
isol
euphorbia
neriifolia
blancoxanthon
isol
root
calophyllum
blancoi
exhibit
activ
tcm
highli
valu
govern
china
campaign
contain
eradi
exampl
health
commiss
provinc
offici
declar
tcm
use
combin
convent
medicin
treatment
patient
februari
nation
health
commiss
nhc
peopl
republ
china
report
confirm
patient
total
confirm
case
treat
tcm
march
total
ongo
clinic
trial
aim
evalu
efficaci
safeti
treatment
patient
launch
china
among
trial
use
tcm
includ
case
examin
effect
combin
treatment
tcm
western
medicin
tcm
trial
effect
selfmad
herbal
prepar
xin
formula
xin
formula
qing
examin
anoth
tcm
trial
commerci
avail
tcm
product
tan
qing
inject
lian
hua
qing
wen
capsul
studi
tabl
date
nhc
publish
edit
guidelin
diagnosi
treatment
sinc
fourth
version
differ
herbal
medicin
use
tcm
system
recommend
treatment
base
stage
diseas
symptom
differenti
accord
latest
edit
guidelin
follow
multipl
compon
chines
herbal
product
recommend
patient
medic
observ
period
presum
prevent
measur
huo
xiang
zheng
qi
shui
lian
hua
qing
wen
capsul
shu
feng
jie
du
capsul
jin
hua
qing
gan
granul
clinic
treatment
period
qing
fei
pai
du
tang
xi
yan
ping
inject
xue
bi
jing
inject
du
ning
inject
tan
qing
inject
xing
nao
jing
inject
chines
medicin
formula
select
addit
patient
critic
condit
shen
fu
inject
sheng
mai
inject
shen
mai
inject
su
xiang
pill
gong
niu
huang
pill
administ
tabl
analysi
frequenc
tcm
use
provinc
luo
et
al
conclud
astragalu
membranaceu
glycyrrhiza
uralensi
saposhnikovia
divaricata
rhizoma
atractylodi
macrocephala
lonicera
japonica
flo
fructu
forsythia
atractylodi
rhizoma
radix
platycodoni
agastach
rugosa
cyrtomium
fortun
j
sm
commonli
use
chines
herb
treatment
xu
et
al
report
astragalu
membranaceu
yu
ping
feng
use
prevent
program
beij
tianjin
et
al
reinforc
vital
qi
terminolog
use
tcm
similar
boost
host
defens
capac
ophiopogon
japonica
scrophularia
ningpoensisand
tcm
herb
frequent
use
nourish
yin
northern
china
atractylodi
rhizoma
agastach
rugosa
chines
medicin
herb
properti
aromat
dehumidif
commonli
use
southern
china
tabl
accord
report
nation
administr
tradit
chines
medicin
februari
patient
treat
qing
fei
pai
du
tang
shanxi
hebei
heilongjiang
shaanxi
provinc
overal
effect
rate
among
symptom
major
patient
markedli
improv
ill
other
stabil
patient
treat
qing
fei
pai
du
tang
provinc
china
result
show
patient
complet
cure
treatment
treatment
also
result
disappear
characterist
symptom
fever
cough
patient
addit
symptom
improv
stabil
observ
patient
patient
respect
yao
et
al
lu
et
al
retrospect
analyz
clinic
efficaci
lian
hua
qing
wen
capsul
treatment
confirm
suspect
patient
result
indic
herbal
product
could
markedli
reliev
major
symptom
fever
cough
capac
promot
recoveri
patient
mild
ill
earli
stage
could
suddenli
progress
sever
diseas
eventu
die
due
septic
shock
multipl
organ
dysfunct
syndrom
mod
associ
cytokin
storm
compel
evid
tcm
herbal
product
compon
potent
immunosuppress
effect
shown
studi
exampl
wang
et
al
report
shen
fu
inject
could
inhibit
lung
inflamm
decreas
level
cytokin
chang
et
al
report
du
ning
inject
could
markedli
reduc
level
cytokin
lpsinduc
model
acut
lung
injuri
rat
recent
report
tetrandrin
compound
isol
antirheumat
chines
herb
could
potent
inhibit
proinflammatori
respons
lpschalleng
mice
therefor
tcm
capac
inhibit
cytokin
storm
devast
consequ
may
har
treatment
sever
patient
current
laboratori
studi
effect
tcm
appar
lag
behind
clinic
applic
tcm
treatment
patient
nevertheless
scientist
start
examin
effect
tcm
product
compon
laboratori
exampl
vitro
studi
show
shuang
huang
lian
oral
liquid
inhibitori
effect
howev
clinic
efficaci
safeti
treatment
patient
evalu
notic
tcm
product
recommend
hnc
guidelin
sarscov
use
receptor
cellular
entranc
theoret
blockad
prevent
infect
chen
du
thu
perform
molecular
dock
studi
found
tcmderiv
compound
includ
baicalin
scutellarin
hesperetin
glycyrrhizin
nicotianamin
could
interact
therefor
compound
well
herb
contain
ingredi
may
capac
inhibit
infect
anticip
experi
studi
show
activ
tcm
compon
publish
near
futur
tcm
accumul
thousandofyear
experi
treatment
pandem
endem
diseas
provid
complementari
altern
treatment
still
urgent
need
manag
patient
infect
experi
tcm
certainli
worth
learn
fight
current
epidem
also
provid
opportun
test
true
valu
tcm
treat
emerg
contagi
diseas
random
doubleblind
placebocontrol
studi
best
way
provid
reliabl
evid
therapi
includ
tcm
encourag
control
clinic
studi
evalu
efficaci
tcm
treatment
sarscov
conduct
report
howev
studi
found
poorli
design
result
could
lead
potenti
bias
evalu
effect
tcm
treatment
hope
current
clinic
studi
evalu
effect
tcm
use
strict
protocol
conceal
alloc
doubleblind
order
ensur
complianc
intern
accept
standard
furthermor
standard
product
tcm
rather
selfprepar
formul
use
clinic
studi
experi
studi
may
abl
elucid
mechan
underli
therapeut
effect
tcm
treatment
studi
tcm
may
lead
identif
novel
anti
human
coronaviru
compound
may
eventu
prove
use
treatment
emerg
fatal
viral
diseas
convent
therapeut
agent
safeti
tcm
treatment
emerg
coronaviru
diseas
includ
observ
sar
patient
report
herb
use
tcm
contain
nephrotoxin
mutagen
toxicolog
featur
chines
herbal
medicin
remain
fulli
understood
furthermor
herb
use
tcm
mimic
magnifi
oppos
effect
convent
medicin
thu
safeti
tcm
use
treatment
emerg
coronaviru
infect
care
evalu
particularli
import
avoid
toxic
interfer
efficaci
convent
treatment
caus
herbdrug
interact
